Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITI with FVIII/vWF concentrates after prior failed VWF-free FVIII tolerance induction in severe hemophilia A with inhibitors
2008-007019-33Phase 4Active
- Sponsor
- Fondazione Angelo Bianchi Bonomi
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of coagulation factor VIII + von Willebrand factor in hemophilia A, sponsored by Fondazione Angelo Bianchi Bonomi. Primary endpoint: Successful induction of immune tolerance. Started Mar 2009; status: active.
02
Drugs
coagulation factor VIII + von Willebrand factor
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2008-007019-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007019-33.